Skip to main content

Meet Daniel

Daniel was diagnosed with severe hemophilia A at 5 months. As a boy, he learned that having hemophilia didn't have to be awkward; that most people would treat him the same as anyone else. To further encourage Daniel to take control of his condition, his mother, Patricia, actively supported his desire to play sports. Daniel understands the challenges of transitioning into adulthood while living with hemophilia. His mission is to speak to young children and teenagers about how to deal with the challenges of growing up with hemophilia.

Please see full Prescribing Information.
Individual results may vary.

USA15HDM01429c
USA15HDM01429c
Play
Pause
Skip
Volume
Chapters
Transcript
References
Subtitles
Fullscreen

Meet Daniel

Chapters
Transcript
References

Daniel was diagnosed with severe hemophilia A at 5 months. As a boy, he learned that having hemophilia didn't have to be awkward; that most people would treat him the same as anyone else. To further encourage Daniel to take control of his condition, his mother, Patricia, actively supported his desire to play sports. Daniel understands the challenges of transitioning into adulthood while living with hemophilia. His mission is to speak to young children and teenagers about how to deal with the challenges of growing up with hemophilia.

Please see full Prescribing Information.
Individual results may vary.

Please see full Prescribing Information.
Please see full Prescribing Information.
Please see full Prescribing Information.
Please see full Prescribing Information.
Please see full Prescribing Information.

Return to overview

Transcripts

Return to overview

References


Selected Important Safety Information

You should not use Novoeight® if you are allergic to factor VIII or any of the other ingredients of Novoeight® or if you are allergic to hamster proteins.

Call your healthcare provider right away and stop treatment if you get any of the following signs of an allergic reaction: rashes or hives, difficulty breathing or swallowing, tightness of the chest, swelling of the lips and tongue, light-headedness, dizziness or loss of consciousness, pale and cold skin, fast heartbeat, or red or swollen face or hands.

Indications and Usage

Novoeight® (Antihemophilic Factor [Recombinant]) is an injectable medicine used to control and prevent bleeding in people with hemophilia A. Your healthcare provider may give you Novoeight® when you have surgery.

Novoeight® is not used to treat von Willebrand Disease.

Important Safety Information

You should not use Novoeight® if you are allergic to factor VIII or any of the other ingredients of Novoeight® or if you are allergic to hamster proteins.

Call your healthcare provider right away and stop treatment if you get any of the following signs of an allergic reaction: rashes or hives, difficulty breathing or swallowing, tightness of the chest, swelling of the lips and tongue, light-headedness, dizziness or loss of consciousness, pale and cold skin, fast heartbeat, or red or swollen face or hands.

Before taking Novoeight®, you should tell your healthcare provider if you have or have had any medical conditions, take any medicines (including non-prescription medicines and dietary supplements), are nursing, pregnant or planning to become pregnant, or have been told that you have inhibitors to factor VIII.

Your body can make antibodies called “inhibitors” against Novoeight®, which may stop Novoeight® from working properly. Call your healthcare provider right away if your bleeding does not stop after taking Novoeight®.

Common side effects of Novoeight® include swelling or itching at the location of injection, changes in liver tests, and fever.

Please click here for Prescribing Information.

Novoeight® is a prescription medication.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800- FDA-1088.